(Q64112742)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Cost-benefit analysis of a national screening programme for cystic fibrosis in an Israeli population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

main subject

cost–benefit analysis

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

Blau H

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Kerem E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Springer C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Kerem BS

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Akstein E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Greenberg A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Kolumbos A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Abeliovich D

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Gazit E

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

language of work or name

English

0 references

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

5-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

The changing epidemiology of cystic fibrosis

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Diabetes mellitus associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Identification of the cystic fibrosis gene: genetic analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Identification of the cystic fibrosis gene: chromosome walking and jumping

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Prenatal screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Carrier screening in CF

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Costs and Benefits of Prenatal Screening for Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Psychological and social consequences of community carrier screening programme for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Chorionic villus sampling: Analysis of fetal losses to delivery, placental pathology, and cervical microbiology

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Risk evaluation of CVS.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Planning for the aftermath.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Successful heart-lung transplantation for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Intermediate-term results of heart-lung transplantation for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Feasibility and cost savings of intravenous administration of aminoglycosides in outpatients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Home intravenous antibiotic treatment of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Antibiotic therapy in cystic fibrosis: evaluation of clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Nutrition support in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Short-term clinical, nutritional, and functional effects of continuous elemental enteral alimentation in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Screening for carriers of cystic fibrosis through primary health care services

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Genetic testing for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Ethical and social issues in screening for genetic disease

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant women

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Diabetes and cystic fibrosis: new questions emerging from increased longevity

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Reduced morbidity in patients with cystic fibrosis detected by neonatal screening

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Sexual concerns of the patient with pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Cystic fibrosis and pregnancy. A national survey

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Functional status as an overall measure of health in adults with cystic fibrosis: further validation of a generic health measure

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Effects of genetic screening on perceptions of health: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

A new approach to prenatal cystic fibrosis carrier screening

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Couple screening for cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

A preliminary trial of couple screening for cystic fibrosis: designing an appropriate information leaflet

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Sickle-Cell Programming — An Imperiled Promise

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

The ovrselling of genetic anxiety.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Genetic Screening: Triumphs, Problems, and Controversies

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Genome project to tackle mass screening

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Impact of genetic counseling: A review of published follow-up studies

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Genetic counselling in cystic fibrosis. Results of a survey of 572 families

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030104

7 January 2021

Identifiers

DOI

10.1002/HEC.4730030104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8167800%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference